Saracatinib inhibits necroptosis and ameliorates psoriatic inflammation by targeting MLKL
Abstract Necroptosis is a kind of programmed cell death that causes the release of damage-associated molecular patterns and inflammatory disease including skin inflammation. Activation of receptor-interacting serine/threonine kinase 1 (RIPK1), RIPK3, and mixed lineage kinase domain-like protein (MLK...
Main Authors: | Jingyi Li, Xingfeng Liu, Yuanyuan Liu, Fangmin Huang, Jiankun Liang, Yingying Lin, Fen Hu, Jianting Feng, Zeteng Han, Yushi Chen, Xuan Chen, Qiaofa Lin, Lanqin Wu, Lisheng Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2024-02-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-024-06514-y |
Similar Items
-
Repurposing of Ibrutinib and Quizartinib as potent inhibitors of necroptosis
by: Fangmin Huang, et al.
Published: (2023-09-01) -
The MLKL kinase-like domain dimerization is an indispensable step of mammalian MLKL activation in necroptosis signaling
by: Yu Zhang, et al.
Published: (2021-06-01) -
The Many Faces of MLKL, the Executor of Necroptosis
by: Veronica Martinez-Osorio, et al.
Published: (2023-06-01) -
HSP70 promotes MLKL polymerization and necroptosis
by: Andrea N. Johnston, et al.
Published: (2020-09-01) -
Examining MLKL phosphorylation to detect necroptosis in murine mammary tumors
by: Jin Young Baik, et al.
Published: (2022-09-01)